Bayes in America
<img src=“Bayes2020.png”, width = “600”, height = “1200” style=“float: right;margin-left: 20px;margin-top: 0px;margin-bottom:0px;">
For the first time ever, the annual Bayes 20XX/Bayesian Biostatistics is going to be held outside Europe — in fact we’re going to be in Washington DC.
It will be an unusual edition — the timing is also very different; normally we have the workshop late May/early June. But this year we’ve defered it to late September to more or less fit with other conferences happening at the FDA. We’ve made a big effort in creating stronger links with the regulators (and the Americans, in particular), so this is certainly a great result for our “Founding Father” Bruno Boulanger!
As usual we have several topics of interest, including the following.
-
The future of the Bayesian Biostatistics in the regulatory world
-
Clinical Innovative Design
-
Bayesian biostatistics for Real World Evidence (RWE)
-
Rare and orphan disease, pediatric development
-
Preventive medicine
-
Meta-analyses, prior elicitation, historical controls, meta-analyses
-
Reproducibility crisis & related topics such as DoE, Assurance (Success…)
-
Non-Clinical Statistics, CMC and related topics (QbD, Stability, bioassays, validation, …)
-
Multivariate models
-
Bayesian inference in complex models (systems biology / PBPK / networks)
-
Bayesian Spatio-temporal/Temporal modelling (e.g. disease propagation, survival analysis,…)
-
Bayesian Decision sciences
-
Benefit/Risk analyses, health economics
-
Bayesian Big Data, predictive models, selection of variables
-
Programming and numerical opportunities
-
Communication of Bayesian statistics
Registrations and call for abstract to open soon!